EUVIMEDEUVIMED entdecken
Open Access

SUV39H2 is a vulnerability in glioblastoma stem cells enhanced by co-targeting SUV39H1

Bihui Cao, Qiqi Xie, Chunying Li, Jensen Mast, Bokai Wang, Qinyi Miao, Chafiq Hamdouchi, Timothy A Grese, Jia Shen

Epigenomics · 2025

DOI: 10.1080/17501911.2025.2568366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epigenomics, 2025. Verfasst von Bihui Cao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical Sciences Program, Indiana University School of Medicine, Bloomington, IN, USA. Hauptthemen laut MEDLINE: Glioblastoma, Neoplastic Stem Cells, Brain Neoplasms, Repressor Proteins. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: ACS-IRG Grant Mechanism, Schwarz Family and Friends Cancer Research Fund, Indiana University Seed Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: To investigate the role of SUV39H2 in glioblastoma (GBM) stem cells (GSCs) and assess whether co-targeting SUV39H2 and SUV39H1 more effectively disrupts GSC maintenance, offering a potential strategy to improve GBM treatment. METHODS: Single-cell RNA-seq was used to assess SUV39H2 expression in GSCs. GSC growth and stemness were evaluated using tumorsphere formation assay and extreme limiting dilution assay. Gene expression at the mRNA and protein levels was measured by RT-qPCR and western blot, respectively. Publicly available datasets were analyzed to investigate SUV39H2 expression patterns and its clinical prognostic significance in GBM and glioma. RESULTS: SUV39H2 is overexpressed in GSCs relative to non-stem GBM cells. Its depletion impairs GSC proliferation and stemness. Co-targeting SUV39H2 and SUV39H1 enhances GSC disruption. High SUV39H2 expression correlates with poor glioma prognosis. CONCLUSION: SUV39H2 is a novel regulator of GSC maintenance. Dual targeting of SUV39H2 and SUV39H1 May offer a potential therapeutic approach for GBM. Glioblastoma (GBM) is the most aggressive type of brain cancer and often comes back after treatment. One reason is the presence of GBM stem cells (GSCs), which can survive therapy and regrow the tumor. In this study, we investigated a protein called SUV39H2, which helps control how DNA is organized and which genes are active. We found that SUV39H2 is expressed at higher levels in GSCs than in other tumor cells. When SUV39H2 was reduced, GSCs grew more slowly and lost their ability to form new tumor spheres in the lab. Blocking both SUV39H2 and a related protein, SUV39H1, made this effect even stronger. Using patient data, we also showed that high levels of SUV39H2 are linked to poorer survival in glioma. These findings suggest that SUV39H2 plays an important role in sustaining GSCs and may be a potential target for improving GBM treatment in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaNeoplastic Stem CellsBrain NeoplasmsRepressor ProteinsHistone-Lysine N-MethyltransferaseHumansCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticPrognosisMethyltransferases

Stichwörter der Autor:innen

GlioblastomaSUV39H1SUV39H2glioblastoma stem cellsstemness

Substanzen

SUV39H1 protein, humanRepressor ProteinsHistone-Lysine N-MethyltransferaseMethyltransferases

Autor:innen und Institutionen

  • Medical Sciences Program, Indiana University School of Medicine, Bloomington, IN, USA.
  • Biochemistry Graduate Program, Indiana University, Bloomington, IN, USA.
  • Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.

Förderung

  • ACS-IRG Grant Mechanism
  • Schwarz Family and Friends Cancer Research Fund
  • Indiana University Seed Grant
  • Indiana University EMPOWER Grant
  • Cancer Drug Discovery and Development Accelerator fund

Zitieren

APA

Cao, B., Xie, Q., Li, C., Mast, J., Wang, B., Miao, Q., Hamdouchi, C., Grese, T. A., & Shen, J. (2025). SUV39H2 is a vulnerability in glioblastoma stem cells enhanced by co-targeting SUV39H1. Epigenomics. https://doi.org/10.1080/17501911.2025.2568366

Vancouver

Cao B, Xie Q, Li C, Mast J, Wang B, Miao Q, et al. SUV39H2 is a vulnerability in glioblastoma stem cells enhanced by co-targeting SUV39H1. Epigenomics. 2025. doi:10.1080/17501911.2025.2568366

BibTeX
@article{Cao2025,
  author = {Cao, Bihui and Xie, Qiqi and Li, Chunying and Mast, Jensen and Wang, Bokai and Miao, Qinyi and Hamdouchi, Chafiq and Grese, Timothy A and Shen, Jia},
  title = {SUV39H2 is a vulnerability in glioblastoma stem cells enhanced by co-targeting SUV39H1},
  journal = {Epigenomics},
  year = {2025},
  doi = {10.1080/17501911.2025.2568366}
}
Kostenlos starten →